Kaz Groen - Cancer Center Amsterdam, Vrije Universiteit Amsterdam

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 35 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Frailty Subgroups Determine Heterogeneous Outcomes in Elderly Patients with Newly-Diagnosed Multiple Myeloma - Long-Term Follow-up of the HOVON 143 Trial

Febe Smits,Kaz Groen, Mark-David Levin,Claudia A M Stege, Roel JW van Kampen, Ellen Van Der Spek, Yavuz M. Bilgin,Noortje Thielen,Inger S. Nijhof,Inge Ludwig,Esther G.M. De Waal,Yorick Sandberg,Alain Kentos,Gert Jan Timmers,Josien C Regelink,Matthijs Westerman, Koen de Heer, Marie Christiane Vekemans,Nazik Durdu-Rayman, Nicole de Graauw,Maarten R. Seefat, Niels W.C.J. van de Donk,Paula F Ypma,Kazem Nasserinejad,Sonja Zweegman

Bloodno. Supplement 1 (2024): 4739-4739

引用0浏览0引用

Long-Term Follow-up from the Phase 2 ICON Study of Iberdomide Combined with Low-Dose Cyclophosphamide and Dexamethasone in Relapsed/Refractory Multiple Myeloma (Ibercd)

Charlotte L.B.M. Korst, Wouter Plattel, Elizabeth de Kort,Alexandra Croockewit, Mark-David Levin,Matthijs Westerman,Okke De Weerdt,Inger S. Nijhof,Jurgen Wegman, Nina Smit,Christie P.M. Verkleij,Tuna Mutis,Marjolein van der Klift,Laurens Franssen,Kaz Groen, Ellen van der Spek, Wilfried Roeloffzen,Sonja Zweegman, Niels W.C.J. van de Donk

Bloodno. Supplement 1 (2024): 3371-3371

引用0浏览0引用

MM-344 Longer-Term Follow-up of Patients Receiving Prophylactic Tocilizumab for the Reduction of Cytokine Release Syndrome (CRS) in the Phase 1/2 MajesTEC-1 Study of Teclistamab in Relapsed/Refractory Multiple Myeloma (RRMM)

Niels WCJ van de Donk,Alfred L Garfall, Lotfi Benboubker,Katarina Uttervall,Kaz Groen, Laura Rosiñol,Jeffrey V Matous,Deeksha Vishwamitra,Caroline Hodin,Tara Stephenson,Keqin Qi,Athena Zuppa,Katherine Chastain,María-Victoria Mateos

Clinical Lymphoma Myeloma and Leukemia (2024)

引用0浏览0引用

Dynamics of Geriatric Impairments Are Associated with Risk of Treatment Discontinuation in Elderly Patients with Multiple Myeloma

Febe Smits,Kazem Nasserinejad, Mark-David Levin,Gert Jan Timmers,Esther G.M. De Waal,Josien C Regelink, Gerjo A. Velders,Matthijs Westerman,Nazik Durdu-Rayman, Suzanne Last-Koopmans, Roel JW van Kampen,Claudia A M Stege,Kaz Groen,Maarten R. Seefat, Monique C. Minnema,Pieter Sonneveld,Paula F Ypma, Niels W.C.J. van de Donk,Sonja Zweegman

Bloodno. Supplement 1 (2024): 3330-3330

引用0浏览0引用

P-074 Longer-Term Follow-Up of Patients Receiving Prophylactic Tocilizumab for Cytokine Release Syndrome in the Phase 1/2 MajesTEC-1 Study of Teclistamab in Relapsed/Refractory Multiple Myeloma

Laura Rosiñol,Alfred Garfall, Lotfi Benboubker,Katarina Uttervall,Kaz Groen,Niels van de Donk, Jeffrey Matous,Deeksha Vishwamitra,Caroline Hodin,Tara Stephenson,Keqin Qi,Athena Zuppa,Katherine Chastain,María-Victoria Mateos Manteca

Clinical Lymphoma Myeloma and Leukemia (2024): S84-S85

引用0浏览0引用

Longer-term Follow-Up of Patients (pts) Receiving Prophylactic Tocilizumab (toci) for the Reduction of Cytokine Release Syndrome (CRS) in the Phase 1/2 MajesTEC-1 Study of Teclistamab in Relapsed/refractory Multiple Myeloma (RRMM)

Laura Rosinol,Alfred Garfall, Lotfi Benboubker,Katarina Uttervall,Kaz Groen,Niels van de Donk,Jeffrey Matous,Deeksha Vishwamitra,Caroline Hodin,Tara Stephenson,Keqin Qi,Athena Zuppa,Katherine Chastain,Maria-Victoria Mateos Manteca

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2024): S84-S85

引用0浏览0引用

Beyond Static Measurements: Dynamic Frailty Improves Survival Prediction in Multiple Myeloma

Febe Smits,Kaz Groen,Mark-David Levin,Claudia A.M. Stege,Roel van Kampen,Ellen van der Spek,Yavuz M. Bilgin,Noortje Thielen,Inger Nijhof,Inge Ludwig,Esther G.M. de Waal,Yorick Sandberg,Alain Kentos,Gert-Jan Timmers,Josien C. Regelink,Matthijs Westerman,Koen de Heer, Marie-Christiane Vekemans,Nazik Durdu-Rayman, Nicole C.H.P. de Graauw

Blood (2024)

引用0浏览0WOS引用

Prophylactic tocilizumab reduces the incidence of cytokine release syndrome in relapsed/refractory myeloma patients treated with teclistamab: Implications for outpatient step-up dosing

Charlotte L B M Korst,Kaz Groen,Patricia W C Bosman, Fleur van der Valk,Christie P M Verkleij,Sandy Kruyswijk, Maaike E M de Ruijter, Dianne M Heijink,Maria T Kuipers,Sonja Zweegman,Niels W C J van de Donk

HemaSphereno. 7 (2024): e132-e132

引用0浏览0WOS引用

Baseline CD57 + and CD16 + NK-Cells Predict Treatment Outcome in Non-Transplant Eligible Newly Diagnosed Multiple Myeloma Patients Treated with Daratumumab-Ixazomib-Dexamethasone

Wassilis S. C. Bruins,Carolien Duetz,Kaz Groen,Charlotte L. B. M. Korst,A. Vera de Jonge,Rosa Rentenaar,Meliha Cosovic,Merve Eken,Inoka Twickler,Paola Homan-Weert,Christie P. M. Verkleij,Kristine A. Frerichs,Niels W. C. J. van de Donk,Sonja Zweegman,Tuna Mutis

BLOOD (2023)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn